ciprofloxacin has been researched along with chalcone in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 4 (44.44) | 2.80 |
| Authors | Studies |
|---|---|
| Do, TH; Huynh, TN; Ngo, TD; Thai, KM; Tran, CD; Tran, NC; Tran, TD | 1 |
| Diana, GD; McKinlay, MA; Otto, MJ | 1 |
| Christensen, SB; Holler, JG; Mølgaard, P; Olsen, CE; Slotved, HC | 1 |
| Abdel-Aziz, M; Abuo-Rahma, Gel-D; Kwon, Y; Park, SE; Sayed, MA | 1 |
| Cui, DT; Hu, GQ; Jin, SJ; Ma, YC; Wang, FQ; Wang, JS; Wang, M; Wang, ZX; Zhang, YX; Zhao, ZJ | 1 |
| Abuo-Rahma, GEA; Alaaeldin, R; Fathy, M; Zhao, QL | 1 |
| Do, TG; Hoang, T; Le, MT; Mai, TT; Ngo, TD; Nguyen, DN; Nguyen, HM; Thai, KM; Tran, TD; Tran-Nguyen, VK; Trinh, DT | 1 |
| Abbas, SH; Abd El-Hafeez, AA; Abourehab, MAS; Abuo-Rahma, GEA; Alhaj-Suliman, SO; Ebeid, K; Ghosh, P; Hayallah, AM; Mekkawy, AI; Mohammed, HHH; Salem, AK; Wafa, EI | 1 |
| Bandeira, PN; Coutinho, HDM; de Andrade, EM; de Freitas, TS; de Lacerda, BCGV; Dos Santos, HS; Marinho, ES; Marinho, MM; Nogueira, CES; Pereira Junior, FN; Pereira, RLS; Rocha, JE; Rodrigues, LG; Teixeira, AMR; Xavier, JC | 1 |
1 review(s) available for ciprofloxacin and chalcone
| Article | Year |
|---|---|
Inhibitors of picornavirus uncoating as antiviral agents.
Topics: Animals; Anti-Infective Agents; Antiviral Agents; Chalcone; Chalcones; Ciprofloxacin; Flavonoids; Fluoroquinolones; Furans; Humans; Isoxazoles; Ketones; Picornaviridae; Picornaviridae Infections; Quinolines; Rhinovirus; Structure-Activity Relationship | 1985 |
8 other study(ies) available for ciprofloxacin and chalcone
| Article | Year |
|---|---|
Synthesis and anti Methicillin resistant Staphylococcus aureus activity of substituted chalcones alone and in combination with non-beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Methicillin-Resistant Staphylococcus aureus; Models, Molecular; Molecular Structure; Structure-Activity Relationship | 2012 |
Chalcone inhibitors of the NorA efflux pump in Staphylococcus aureus whole cells and enriched everted membrane vesicles.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biological Transport; Chalcone; Ciprofloxacin; Drug Synergism; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Staphylococcus aureus | 2012 |
Novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids: synthesis, physicochemical properties, anticancer and topoisomerase I and II inhibitory activity.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chalcone; Ciprofloxacin; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Piperazines; Structure-Activity Relationship; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 2013 |
Dual Inhibition of Topoisomerase II and Tyrosine Kinases by the Novel Bis-Fluoroquinolone Chalcone-Like Derivative HMNE3 in Human Pancreatic Cancer Cells.
Topics: Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Chalcone; Ciprofloxacin; DNA Topoisomerases, Type II; Humans; Pancreatic Neoplasms; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Topoisomerase II Inhibitors | 2016 |
Modulation of Apoptosis and Epithelial-Mesenchymal Transition E-cadherin/TGF-β/Snail/TWIST Pathways by a New Ciprofloxacin Chalcone in Breast Cancer Cells.
Topics: Apoptosis; Breast Neoplasms; Cadherins; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Survival; Chalcone; Ciprofloxacin; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Molecular Structure; Proteins; Signal Transduction; Snail Family Transcription Factors; Transforming Growth Factor beta; Twist-Related Protein 1 | 2021 |
Chalcone Derivatives as Potential Inhibitors of P-Glycoprotein and NorA: An
Topics: Anti-Bacterial Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bacterial Proteins; Chalcone; Ciprofloxacin; Humans; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins | 2022 |
New 1,2,3-triazole linked ciprofloxacin-chalcones induce DNA damage by inhibiting human topoisomerase I& II and tubulin polymerization.
Topics: Antineoplastic Agents; Caco-2 Cells; Cell Line, Tumor; Cell Proliferation; Chalcone; Chalcones; Ciprofloxacin; DNA Damage; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Doxorubicin; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Polymerization; Structure-Activity Relationship; Triazoles; Tubulin | 2022 |
ADMET study, spectroscopic characterization and effect of synthetic nitro chalcone in combination with norfloxacin, ciprofloxacin, and ethidium bromide against Staphylococcus aureus efflux pumps.
Topics: Anti-Bacterial Agents; Chalcone; Chalcones; Ciprofloxacin; Ethidium; Humans; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Norfloxacin; Staphylococcal Infections; Staphylococcus aureus | 2023 |